| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850704 | American Journal of Kidney Diseases | 2008 | 9 Pages |
Abstract
A substantial proportion of participating patients met criteria for an anxiety disorder. The utility of the HADS as a screening tool for anxiety in patients with ESRD should be questioned. The finding that anxiety disorders negatively impact on QOL and are not merely manifestations of depression in patients with ESRD emphasizes the importance of accurate diagnosis and effective treatment. Strategic options are necessary to improve the diagnosis of anxiety disorders, potentially enhancing QOL and medical outcome in patients with ESRD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Daniel PhD, Jeremy MD, Clinton MD, Steven PhD, Howard BA, Michal BA, Lisa A. PhD, Rolf A. PhD, Paul L. MD,